[1]
M. Uchida, T. Kawashiri, N. Maegawa, A. Takano, K. Hosohata, and Y. Uesawa, “Pharmacovigilance Evaluation of Bendamustine-related Skin Disorders using the Japanese Adverse Drug Event Report Database”, J Pharm Pharm Sci, vol. 24, pp. 16–22, Jan. 2021.